Thrombosis and a hypercoagulable state in HIV-infected patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 10, Issue 3, 2004, Pages 277-280

  Shen, Yu Min P ^a   Frenkel, Eugene P ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Highly active antiretroviral therapy; Human immunodeficiency virus; Hypercoagulable state; Opportunistic infections; Platelet activation; Protease inhibitors; Protein S deficiency

Indexed keywords

ANTIRETROVIRUS AGENT; CARDIOLIPIN ANTIBODY; INDINAVIR; PHOSPHOLIPID ANTIBODY; PROTEIN S; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; HEART INFARCTION; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABILITY; INCIDENCE; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM; THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASPIRIN; COHORT STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INCIDENCE; INDINAVIR; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

EID: 3242781715     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960401000311     Document Type: Article

References (28)

1. Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS. Hematol Oncol Clin North Am 1991;5:195.
2. Gervasoni C, Ridolfo AL, Vaccarezza M, et al. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis 2002;35:1534.
3. Sullivan PS, Dworkin MS, Jones JL, et al. Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS 2000;14:321.
4. Saber AA, Aboolian A, LaRaja RD, et al. HIV/AIDS and the risk of deep vein thrombosis: A study of 45 patients with lower extremity involvement. Am Surg 2001;67:645.
5. Copur AS, Smith PR, Gomez V, et al. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS 2002;16:205.
6. Saif MW, Bona R, Greenberg B. AIDS and thrombosis: Retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001;15:311.
7. Saif MW, Greenberg B. HIV and thrombosis: A review. AIDS Patient Care STDS 2001;15:15.
8. Feffer SE, Fox RL, Orsen MM, et al. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 1995;88:1126.
9. Erbe M, Rickerts V, Bauersachs RM, et al. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost 2003, submitted for publication.
10. Stahl CP, Wideman CS, Spira TJ, et al. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993;81:1801.
11. Sugerman RW, Church JA, Goldsmith JC, et al. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1996;15:106.
12. Sorice M, Griggi T, Arcieri P, et al. Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies. Thromb Res 1994;73:165.
13. Bissuel F, Berruyer M, Causse X, et al. Acquired protein S deficiency: Correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr 1992;5:484.
14. Hassell KL, Kressin DC, Neumann A, et al. Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men. Blood Coagul Fibrinolysis 1994;5:455.
15. Janier M, Flageul B, Drouet L, et al. Cutaneous and plasma values of von Willebrand factor in AIDS: A marker of endothelial stimulation? J Invest Dermatol 1988;90:703.
16. Lafeuillade A, Alessi MC, Poizot-Martin I, et al. Endothelial cell dysfunction in HIV Infection. J Acquir Immune Defic Syndr 1992;5:127.
17. Blann AD, Seigneur M, Constans J, et al. Soluble P-selectin, thrombocytopenia and von Willebrand factor in HIV infected patients. Thromb Haemost 1997;77:1221.
18. Blann A, Constans J, Dignat-George F, et al. The platelet and endothelium in HIV infection. Br J Haematol 1998;100:613.
19. Schecter AD, Berman AB, Yi L, et al. HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci USA 2001;98:10142.
20. Carr A, Brown D, Cooper DA. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. AIDS 1997;11:1657.
21. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995;95:995.
22. Simon DI, Vaughan DE. Cathepsin D-like aspartyl protease activity mediates the degradation of tissue-type plasminogen activator/plasminogen activator inhibitor-1 complexes in human monocytes. Biochim Biophys Acta 1995;1268:143.
23. Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328.
24. George SL, Swindells S, Knudson R, et al. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: Report of seven cases. Am J Med 1999;107:624.
25. Pulik M, Jary L, Genet P, et al. Coagulation studies in non-hemophiliac HIV-infected patients treated with protease inhibitors. In Fourth Conference on Retroviruses and Opportunistic Infections abstract 201, 1997.
26. Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R, et al. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost 2003, submitted for publication.
27. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457.
28. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993.